Condition: Lipoprotein (a) · Sponsor: University of Central Florida
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
This description comes directly from the study's public registry record.
Amoy Fraser, PhD, CCRP, PMP · 14072668742 · Amoy.Fraser@UCF.edu
Britney-Ann Wray, BS, CTBS, CCRP · 4072668742 · Britney-Ann.Wray@UCF.edu
Always discuss trial participation with your own doctor first.
| University of Central Florida | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07579325